Loading…
Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015 This bill amends the Internal Revenue Code to allow a business-related tax credit for the production of renewable chemicals. The bill defines "renewable chemical" as any chemical that: (1) is produced in the United States from renewable biomass; (2) is sold or used for the production of chemical products, polymers, plastics, or formulated products or as chemicals, polymers, plastics, or formulated products; (3) has a biobased content of 95% or higher; (4) is the product of, or reliant upon, biological or thermal conversion of renewable biomass; (5) is not sold or used for the production of any food, feed, or fuel; and (6) is not a combination of certain specified renewable chemicals. The bill also allows a tax credit for investment in renewable chemical production facilities. The bill requires the Department of the Treasury to establish a program to allocate renewable chemical tax credit amounts to eligible taxpayers and imposes an aggregate limit on the amount of credits that may be allocated to not more than $500 million during the 5-year period after enactment of this Act.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2016 · fourth_quarter · Taxation/Internal Revenue Code
H.R.880, American Research and Competitiveness Act of 2015 HR 3390, The Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015 S. 2271, Renewable Chemicals Act
Client expense: $50,000 · Firm income: Not reported
Referred to the House Committee on Ways and Means.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Taxation/Internal Revenue Code
Biofuels (Non-Funding) ---Production Tax Credit Extension Capital Formation Investment Incentives ---Reform of Capital Gains Rules ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules ---S. 341: Start-up Jobs and Innovation Act ---H.R. 2179: PARTNER Act ---S. 537: COMPETE Act Inversions ---H.R.5485-S.3067: Financial Services and General Government Appropriations Act for FY 2017 Treatment of Financial Interests as Stock or Indebtedness ---Section 385 Proposed Regulations Orphan Drug Act Tax Credit No sub-issues Renewable Chemicals/Bio-based Products (Non-Funding) ---Investment Tax Credit for Renewable Chemicals and Bio-based Products ---New Production Tax Credit ---H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act ---S. 2271: The Renewable Chemical Production Tax Credit Act
Client expense: $2,330,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, U.S. Trade Representative (USTR)
2016 · fourth_quarter · Chemicals/Chemical Industry
Funding for Renewable Chemicals/Bio-based Products ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for FY 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 Renewable Chemicals/Bio-based Products (Non-Funding) ---Expansion of Master Limited Partnerships to Renewable Chemicals ---Investment Tax Credit for Renewable Chemicals and Bio-based Products ---New Production Tax Credit ---Reauthorization of USDA Bio-Preferred Program ---S. 1656/H.R. 2883: Master Limited Partnership Parity Act ---S. 2271: The Renewable Chemical Production Tax Credit Act ---H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act
Client expense: $2,330,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), SENATE, U.S. Trade Representative (USTR)
2016 · fourth_quarter · Taxation/Internal Revenue Code
H.R.880, American Research and Competitiveness Act of 2015 HR 3390, The Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015 S. 2271, Renewable Chemicals Act
Client expense: $50,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · fourth_quarter · Taxation/Internal Revenue Code
Tax policy issues and business tax issues and IRS regulations. H.R. 880 - American Research and Competitiveness Act of 2015, S. 2271, Renewable Chemicals Act of 2015 and H.R. 3390, Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015.
Client expense: $150,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2016 · third_quarter · Chemicals/Chemical Industry
Funding for Renewable Chemicals/Bio-based Products ---H.R. 4909/S.2943: National Defense Authorization Act (NDAA) for 2017 ---H.R. 5293/S.3000: Department of Defense Appropriations Act for FY 2017 Renewable Chemicals/Bio-based Products (Non-Funding) ---Expansion of Master Limited Partnerships to Renewable Chemicals ---H.R. 2576: TSCA Modernization Act ---H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act ---Implementation of the Agricultural Act of 2014 ---Investment Tax Credit for Renewable Chemicals and Bio-based Products ---Nomenclature Usage ---Reauthorization of USDA Bio-Preferred Program ---S. 1656/H.R. 2883: Master Limited Partnership Parity Act ---S. 2271: The Renewable Chemical Production Tax Credit Act
Client expense: $2,330,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of Technology Policy (OTP), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Vice President of the U.S.
2016 · third_quarter · Taxation/Internal Revenue Code
Antibiotic & Diagnostic Tax Credit ---H.R. 3539: Antibiotic & Diagnostic Innovation Act Biofuels (Non-Funding) ---Production Tax Credit Extension Capital Formation Investment Incentives ---H.R. 2179: PARTNER Act ---Reform of Capital Gains Rules ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules ---S. 341: Start-up Jobs and Innovation Act ---S. 537: COMPETE Act Inversions ---Treatment of Financial Interests as Stock or Indebtedness: Section 385 Proposed Regulations Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act ---Investment Tax Credit for Renewable Chemicals and Bio-based Products ---S. 2271: The Renewable Chemical Production Tax Credit Act ---S. 1656/H.R. 2883: Master Limited Partnership Parity Act ---Expansion of Master Limited Partnerships to Renewable Chemicals Research & Development Tax Credit Reforms ---Extension ---H.R.880: To amend the Internal Revenue Code to make permanent the credit for increasing research activities ---Permanency ---Refundable R&D Credit ---S. 341: Start-up Jobs and Innovation Act ---S. 537: COMPETE Act Orphan Drug Tax Credit
Client expense: $2,330,000 · Firm income: Not reported
2016 · third_quarter · Taxation/Internal Revenue Code
H.R.880, American Research and Competitiveness Act of 2015 H.R. 3390, Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015 S. 2271, Renewable Chemicals Act
Client expense: $90,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Taxation/Internal Revenue Code
Tax policy issues and business tax issues and IRS regulations. H.R. 880 - American Research and Competitiveness Act of 2015, S. 2271, Renewable Chemicals Act of 2015 and H.R. 3390, Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015.
Client expense: $140,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Trade Representative (USTR)
2016 · second_quarter · Taxation/Internal Revenue Code
Antibiotic & Diagnostic Tax Credit ---H.R. 3539: Antibiotic & Diagnostic Innovation Act Biofuels (Non-Funding) ---Accelerated Depreciation of Biofuels Facilities Extension ---Production Tax Credit Extension Capital Formation Investment Incentives ---H.R. 2179: PARTNER Act ---Reform of Capital Gains Rules ---Reform of Net Operating Loss Rules ---Reform of Passive Loss Rules ---S. 341: Start-up Jobs and Innovation Act ---S. 537: COMPETE Act Inversions ---H.R.5485-S.3067: Financial Services and General Government Appropriations Act for FY 2017 Orphan Drug Act Tax Credit Renewable Chemicals/Bio-based Products (Non-Funding) ---H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act ---Investment Tax Credit for Renewable Chemicals and Bio-based Products ---New Production Tax Credit ---S. 2271: The Renewable Chemical Production Tax Credit Act Research & Development Tax Credit Reforms ---Refundable R&D Credit
Client expense: $2,310,000 · Firm income: Not reported
2016 · second_quarter · Chemicals/Chemical Industry
EPA Regulations on Biotechnology ---Efficient Science-Based Review of Biotech Products ---Reauthorization of Pesticide Registration Improvement Act (PRIA) ---EPA Points to Consider Guidance Document for GE Algae Funding for Renewable Chemicals/Bio-based Products ---H.R.5055 - S.2804: Energy and Water Development and Related Agencies Appropriations Act for FY 2017 Renewable Chemicals/Bio-based Products (Non-Funding) ---Implementation of the Agricultural Act of 2014 ---Investment Tax Credit for Renewable Chemicals and Bio-based Products ---New Production Tax Credit ---Nomenclature Usage ---Pre-market Notification Review ---Reauthorization of USDA Bio-Preferred Program ---H.R. 2576: TSCA Modernization Act ---H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act ---S. 2271: The Renewable Chemical Production Tax Credit Act ---S. 696: The Safe Chemicals Act ---S. 697: Frank R. Lautenberg Chemical Safety for 21st Century Act
Client expense: $2,310,000 · Firm income: Not reported
2016 · second_quarter · Taxation/Internal Revenue Code
H.R.880, American Research and Competitiveness Act of 2015 H.R. 3390, Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015 S. 2271, Renewable Chemicals Act
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Taxation/Internal Revenue Code
Tax policy issues and business tax issues and IRS regulations. H.R. 880 - American Research and Competitiveness Act of 2015, S. 2271, Renewable Chemicals Act of 2015 and H.R. 3390, Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015.
Client expense: $100,000 · Firm income: Not reported
Government targets: Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Office of Management & Budget (OMB), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Surface Transportation Board (STB), Transportation, Dept of (DOT), U.S. Trade Representative (USTR)
2016 · first_quarter · Energy/Nuclear
Funding for Renewable Chemicals/Bio-based Products --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 EPA Regulation of Biotechnology --EPA Points to Consider Guidance Document for GE Algae Energy Basic Research Funding --Advanced Research Projects Agency --DOE Office of Science --Energy and Water Development and Related Agencies Appropriations Act for FY 2017 Funding for Biofuels --Department of Defense Funding of Advanced Biofuels --Energy and Water Development and Related Agencies Appropriations Act for FY 2017 Renewable Fuel Standard --The 2014-2016 Final Rule --Departments of Interior, and Related Agencies Appropriations Act for FY 2017 Review of the Federal Coordinated Framework for Biotechnology Products Renewable Chemicals/Bio-based Products (Non-Funding) --Implementation of the Agricultural Act of 2014 --Investment Tax Credit for Renewable Chemicals and Bio-based Products --Nomenclature Usage --Reauthorization of USDA Bio-Preferred Program --S. 2271: The Renewable Chemicals Act --S. 1656/H.R. 2883: Master Limited Partnership Parity Act --H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act --H.R. 2576: TSCA Modernization Act --S.697: Frank R. Lautenberg Chemical Safety for the 21st Century Act Biofuels (Non-Funding) --Production Tax Credit Extension --S. 1239/H.R. 1736: to amend the Clean Air Act with respect to the ethanol waiver for the Reid vapor pressure limitations under that Act --S. 2658: Federal Aviation Administration Reauthorization Act of 2016 ----Franken-Grassley Amendment Funding for Biomass Crop Assistance Program --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Client expense: $2,260,000 · Firm income: Not reported
2016 · first_quarter · Chemicals/Chemical Industry
Funding for Renewable Chemicals/Bio-based Products --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 Renewable Chemicals/Bio-based Products (Non-Funding) --Nomenclature Usage --S. 2271: The Renewable Chemicals Act --S. 1656/H.R. 2883: Master Limited Partnership Parity Act --H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act --H.R. 2576: TSCA Modernization Act --S.697: Frank R. Lautenberg Chemical Safety for the 21st Century Act --Implementation of the Agricultural Act of 2014 --Reauthorization of USDA Bio-Preferred Program --Investment Tax Credit for Renewable Chemicals and Bio-based Products EPA Regulations on Biotechnology --Reauthorization of Pesticide Registration Improvement Act (PRIA)
Client expense: $2,260,000 · Firm income: Not reported
2016 · first_quarter · Fuel/Gas/Oil
Funding for Renewable Chemicals/Bio-based Products --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017 EPA Regulation of Biotechnology --EPA Points to Consider Guidance Document for GE Algae Energy Basic Research Funding --Advanced Research Projects Agency --DOE Office of Science --Energy and Water Development and Related Agencies Appropriations Act for FY 2017 Funding for Biofuels --Department of Defense Funding of Advanced Biofuels --Energy and Water Development and Related Agencies Appropriations Act for FY 2017 Renewable Fuel Standard --The 2014-2016 Final Rule --Departments of Interior, and Related Agencies Appropriations Act for FY 2017 Review of the Federal Coordinated Framework for Biotechnology Products Renewable Chemicals/Bio-based Products (Non-Funding) --Implementation of the Agricultural Act of 2014 --Investment Tax Credit for Renewable Chemicals and Bio-based Products --Nomenclature Usage --Reauthorization of USDA Bio-Preferred Program --S. 2271: The Renewable Chemicals Act --S. 1656/H.R. 2883: Master Limited Partnership Parity Act --H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act --H.R. 2576: TSCA Modernization Act --S.697: Frank R. Lautenberg Chemical Safety for the 21st Century Act Biofuels (Non-Funding) --Production Tax Credit Extension --S. 1239/H.R. 1736: to amend the Clean Air Act with respect to the ethanol waiver for the Reid vapor pressure limitations under that Act --S. 2658: Federal Aviation Administration Reauthorization Act of 2016 ----Franken-Grassley Amendment Funding for Biomass Crop Assistance Program --Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2017
Client expense: $2,260,000 · Firm income: Not reported
2016 · first_quarter · Taxation/Internal Revenue Code
Biofuels (Non-Funding) --Production Tax Credit Extension --S. 2658: Federal Aviation Administration Reauthorization Act of 2016 ----Franken-Grassley Amendment Research & Development Tax Credit Reforms --Extension --Permanency --Refundable R&D Credit Capital Formation Investment Incentives --H.R. 2179: PARTNER Act --Reform of Capital Gains Rules --Reform of Net Operating Loss Rules --Reform of Passive Loss Rules --S. 341: Start-up Jobs and Innovation Act --S. 537: COMPETE Act Tax Reform --Innovation Box / Patent Box Orphan Drug Act Tax Credit Antibiotic & Diagnostic Tax Credit --H.R. 3539: Antibiotic & Diagnostic Innovation Act Inversions --Financial Services and General Government Appropriations Act for FY 2017 Renewable Chemicals/Bio-based Products (Non-Funding) --Investment Tax Credit for Renewable Chemicals and Bio-based Products --S. 2271: The Renewable Chemicals Act --S. 1656/H.R. 2883: Master Limited Partnership Parity Act --H.R. 3390: Qualifying Renewable Chemicals Production or Investment Tax Credit Act  
Client expense: $2,260,000 · Firm income: Not reported
2016 · first_quarter · Taxation/Internal Revenue Code
Tax policy issues and business tax issues. R&D Tax Credits. H.R. 880 - American Research and Competitiveness Act of 2015, S. 2271, Renewable Chemicals Act of 2015 and H.R. 3390, Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015.
Client expense: $180,000 · Firm income: Not reported
Government targets: Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Surface Transportation Board (STB), U.S. Trade Representative (USTR)
2016 · first_quarter · Taxation/Internal Revenue Code
H.R.880, American Research and Competitiveness Act of 2015 H.R. 3390, Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2015 · fourth_quarter · Taxation/Internal Revenue Code
Tax policy issues and business tax issues. R&D Tax Credits. H.R. 880 - American Research and Competitiveness Act of 2015. S. 2271 - Renewable chemicals Act of 2015. H.R. 3390 - Qualifying Renewable Chemical Production or Investment Tax Credit Act of 2015.
Client expense: $100,000 · Firm income: Not reported
Government targets: Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Federal Railroad Administration, HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE, State, Dept of (DOS), Tennessee Valley Authority (TVA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
| Democratic |
| MA |
| Richard M. Nolan | Democratic | MN |
| Ryan A. Costello | Republican | PA |
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Economic Council (NEC), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of Technology Policy (OTP), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Vice President of the U.S.
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, U.S. Trade Representative (USTR), White House Office
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), SENATE, U.S. Trade Representative (USTR), White House Office
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)